Evidence map›Paper›PMID 25793109›Full record

ArticleActa radiologica open2015

Intra-individual comparison of PET/CT with different body weight-adapted FDG dosage regimens.

Jan H Geismar, Paul Stolzmann, Bert-Ram Sah, Irene A Burger, Burkhardt Seifert, Gaspar Delso, Gustav K von Schulthess, Patrick Veit-Haibach, Lars Husmann

Open access · goldAbstract read
In one paragraph

Article in Acta radiologica open, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Improved [Quantitative imaging in medicine and surgery · 2023
    Article
  3. Article
  4. Influences on PET Quantification and Interpretation.Diagnostics (Basel, Switzerland) · 2022
    Review
  5. A dedicated paediatric [EJNMMI research · 2021
    Article
  6. Standardized image quality forEJNMMI research · 2020
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jan H GeismarDivision of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland ; Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.
Paul StolzmannDivision of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland ; Division of Neuroradiology, University Hospital Zurich, Zurich, Switzerland ; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
Bert-Ram SahDivision of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Irene A BurgerDivision of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland ; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
Burkhardt SeifertDivision of Biostatistics, Institute of Social- and Preventive Medicine, University of Zurich, Switzerland.
Gaspar DelsoDivision of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland ; GE Healthcare, Waukesha, Wisconsin, USA.
Gustav K von SchulthessDivision of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Patrick Veit-HaibachDivision of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland ; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
Lars HusmannDivision of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
University Hospital of Zurich · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background18F-2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET)/ computed tomography (CT) imaging demands guidelines to safeguard sufficient image quality at low radiation exposure. Various FDG dose regimes have been investigated; however, body weight-adapted dose regimens and related image quality (IQ) have not yet been compared in the same patient. PURPOSE: To investigate the relationship between FDG dosage and image quality in PET/CT in the same patient and determine prerequisites for low dosage scanning. MATERIAL AND

methodsThis study included 61 patients undergoing a clinically indicated PET/CT imaging study and follow-up with a normal (NDS, 5 MBq/kg body weight [BW]) and low dosage scanning protocol (LDS, 4 MBq/kg BW), respectively, using a Discovery VCT64 scanner. Two blinded and independent readers randomly assessed IQ of PET using a 5-point Likert scale and signal-to-noise ratio (SNR) of the liver.

resultsBody mass index (BMI) was significantly lower at LDS (P = 0.021) and represented a significant predictor of SNR at both NDS (P < 0.001) and LDS (P = 0.005). NDS with a mean administered activity of 340 MBq resulted in significantly higher IQ (P < 0.001) and SNR as compared with LDS with a mean of 264 MBq (F-value = 23.5, P < 0.001, mixed model ANOVA adjusted for covariate BMI). Non-diagnostic IQ at LDS was associated with a BMI > 22 kg/m(2).

conclusionFDG dosage significantly predicts IQ and SNR in PET/CT imaging as demonstrated in the same patient with optimal IQ achieved at 5 MBq/kg BM. PET/CT imaging at 4 MBq/kg BW may only be recommended in patients with a BMI ≤ 22 kg/m(2) to maintain diagnostic IQ.

Indexed as

18F-fluorodeoxyglucose (18F-FDG)computed tomography (CT)dosageimage enhancementMedical oncologypositron-emission tomography (PET)radiation protection

Identifiers

PMID25793109
PMCPMC4364401
OpenAlexW2030808296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.